Sabra Health Care REIT (SBRA) EBIT Margin (2016 - 2026)
Sabra Health Care REIT has reported EBIT Margin over the past 11 years, most recently at 58.13% for Q1 2026.
- For Q1 2026, EBIT Margin fell 2916.0% year-over-year to 58.13%; the TTM value through Mar 2026 reached 53.27%, up 153980.0%, while the annual FY2025 figure was 34.33%, 5121.0% down from the prior year.
- EBIT Margin for Q1 2026 was 58.13% at Sabra Health Care REIT, up from 25.93% in the prior quarter.
- Over five years, EBIT Margin peaked at 162.66% in Q1 2022 and troughed at 31.85% in Q4 2024.
- A 5-year average of 54.36% and a median of 58.13% in 2026 define the central range for EBIT Margin.
- Biggest five-year swings in EBIT Margin: surged 12095bps in 2022 and later plummeted -14991bps in 2023.
- Year by year, EBIT Margin stood at 11.49% in 2022, then surged by 759bps to 75.71% in 2023, then plummeted by -142bps to 31.85% in 2024, then soared by 181bps to 25.93% in 2025, then skyrocketed by 124bps to 58.13% in 2026.
- Business Quant data shows EBIT Margin for SBRA at 58.13% in Q1 2026, 25.93% in Q4 2025, and 55.02% in Q3 2025.